1000 Mg Cyclophosphamide Injection IP

Name: 1000 Mg Cyclophosphamide Injection IP
Brand: GloBio Pharma
Price: 70 INR
Availability: InStock

Price 70 INR/ Vial

Get a Price/Quote

MOQ : 50 Vials

1000 Mg Cyclophosphamide Injection IP Specification

Indication
Cancer, Immunosuppressive therapy

Salt Composition
Cyclophosphamide IP

Dosage Form
Injection

Feature
Prescription only, Hospital supply

Ingredients
Cyclophosphamide

Application
IV injection, Oncology

Physical Color/Texture
Powder for injection (to be reconstituted)

Storage Instructions
Store below 25C

Injection Type
Solution

Single use vial
Yes

For intravenous use
Yes

Strength
1000 mg

Reconstitution required
Yes

Packaging Type
Box

Packaging Size
1 Vial

Prescription Type
Hospital Supply

Cytotoxic agent
Yes

Form
Injection

1000 Mg Cyclophosphamide Injection IP Trade Information

Minimum Order Quantity
50 Vials

Payment Terms
Cash in Advance (CID)

Supply Ability
100 Vials Per Month

Delivery Time
7 Days

Main Domestic Market
All India

About 1000 Mg Cyclophosphamide Injection IP

Introducing the new 1000 Mg Cyclophosphamide Injection IP, a popular choice in oncology and immunosuppressive therapy. Crafted as a single-use masterpiece, this cytotoxic agent is supplied in a 1-vial box, ensuring hospital-grade precision and safety. Its unrivaled efficacy delivers breathtaking results in cancer treatment, elevating standards in medical care. Reconstitution is required before use, making it ideal for intravenous administration. Jump on this advanced solution for your healthcare facility-trusted by leading exporters, manufacturers, suppliers, and traders across India. For hospital supply and prescription use only.

Unrivaled Advantages & Users of Cyclophosphamide 1000 Mg Injection

The 1000 Mg Cyclophosphamide Injection IP stands out with its potent effect against cancer, providing a reliable option in immunosuppressive therapy. Favored by oncologists and hospital care professionals, this solution gives medical teams a trusted approach to complex conditions. Its primary competitive advantages include high purity, rapid action, and consistency backed by verified manufacturing standards. This injection is widely adopted by top hospitals, research centers, and clinics seeking excellence in patient outcomes.

Packaging & Export Details of 1000 Mg Cyclophosphamide Injection IP

Packaged securely in a single-use vial within a sturdy box, the 1000 Mg Cyclophosphamide Injection IP is designed for robust hospital supply and international export markets. Sale prices are competitive, reflecting comprehensive quality standards. Each shipment features secure shipping to maintain product stability and integrity. Delivery times are prompt and reliable, with FOB port services available across India. Our export channels cater to global hospital networks, ensuring rapid and accurate order fulfillment.

FAQ's of 1000 Mg Cyclophosphamide Injection IP:

Q: How should the 1000 Mg Cyclophosphamide Injection IP be administered?

A: This injection is designed for intravenous use. The powder must be reconstituted prior to administration under hospital supervision by qualified healthcare professionals.

Q: What are the primary indications for Cyclophosphamide Injection IP?

A: It is primarily indicated for cancer treatment and immunosuppressive therapy, offering significant benefits in oncology and related specialties.

Q: When is it necessary to use this injection as part of treatment?

A: Cyclophosphamide Injection IP is used when intravenous chemotherapy or immunosuppression is required, as determined by an attending physician based on patient diagnosis.

Q: Where is Cyclophosphamide Injection IP typically supplied?

A: This product is available exclusively through hospital supply chains and is distributed by approved exporters, manufacturers, and suppliers, particularly in India.

Q: What is the process for preparing Cyclophosphamide Injection IP before use?

A: The injection comes as a powder that must be reconstituted with a suitable solvent before IV administration. This process should be performed in a controlled medical setting.